Graves' disease following allogenic hematopoietic stem cell transplantation for severe aplastic anemia: case report and literature review

Paketci A., DEMİR K., TÜFEKÇİ Ö., Acar S., ABACI A., YILMAZ Ş., ...More

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, vol.31, no.5, pp.589-593, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 31 Issue: 5
  • Publication Date: 2018
  • Doi Number: 10.1515/jpem-2017-0358
  • Journal Name: JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.589-593
  • Keywords: allogenic hematopoietic stem cell transplantation, Graves' disease, hyperthyroidism, severe aplastic anemia, BONE-MARROW-TRANSPLANTATION, ANTITHYMOCYTE GLOBULIN, IN-VITRO, THYROTOXICOSIS, CHILDHOOD, RECIPIENT, OUTCOMES, HORSE, DONOR
  • Dokuz Eylül University Affiliated: Yes

Abstract

Background: Similar autoimmune processes (defective T-cell function) take place during the pathogenesis of aplastic anemia (AA) and Graves' disease (GD). Antithyroid drugs used for the management of GD may induce AA and GD may occur following treatment of severe aplastic anemia (SAA).